Page last updated: 2024-11-02

pamidronate and Carcinoma, Papillary

pamidronate has been researched along with Carcinoma, Papillary in 1 studies

Carcinoma, Papillary: A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"We found that urinary markers of bone resorption are best measured on 2-hour fasting samples, because results on random urine showed poor precision and less decline with therapy."2.69Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates. ( Garber, J; Greenspan, SL; Lee, SL; Moses, AC; Rosen, HN; Ross, DS, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosen, HN1
Moses, AC1
Garber, J1
Ross, DS1
Lee, SL1
Greenspan, SL1

Trials

1 trial available for pamidronate and Carcinoma, Papillary

ArticleYear
Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates.
    Calcified tissue international, 1998, Volume: 63, Issue:5

    Topics: Alkaline Phosphatase; Amino Acids; Antineoplastic Agents; Biomarkers; Bone and Bones; Bone Resorptio

1998